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1000 iterations. We then backed the alignment to its corresponding coding sequences.
After getting conserved blocks from sequence alignment by Gblocks v0.91b [22, 23] , we used jModelTest v2. 1.6 [24, 25] to find the best substitution model according to Bayesian Information Criterion. Afterwards, PhyML 20141106[26] were used to reconstruct phylogenetic tree under the best substitution model 012212+G+I, in which gamma was 1.32 and proportion invariable sites was 0.13, with bootstrapping of 1000 replicates. WebLogo was used to visualize the sequence alignment [27] .
Sequences of the Speedy family from species belonging to Catarrhini were extracted.
We found that the length of them varied wildly, which was not suitable for further analysis. Sequences meeting the following criteria were removed from further analysis: a Spy1 domain length shorter than 100aa; if the start site of Spy1 domain was at the beginning of sequence, which is shorter than 180aa. We then used the same protocol described above to reconstruct the phylogenetic tree by using cds sequences.
The best model for phylogenetic tree reconstruction was 012010+G (with gamma = 3.59). Type and diversity of the Speedy family were detected by DIVERGE 3.0 Beta 1 [28, 29] . PAML 4.8 [30, 31] was used to detect positive selection for Speedy E family in Catarrhini with branch-site model and calculate the dN/dS ratio for low-Spy1-identity domain sequences. Sequence alignment were visualized by WebLogo[27] . Coding potential score for human and chimpanzee Speedy members were obtained from the Coding Potential Calculator [32] .
SNP data in cds and cdna region of genes and pseudogenes of Speedy family were extracted from the 1000 Genomes Project Phase 3 data [33] . For protein-coding genes 8 of the human Speedy family, SNPs which could be a result of the stop codon were extracted, and if simultaneous SNPs around adjacent sites led to a stop codon, individual data were then used to determine whether there were simultaneous mutations within these sites in each individual. As for pseudogenes, we focused on SNPs which could change a stop codon in the middle of coding region to a code for an amino acid. We also extract CNV data in genes and pseudogenes of the Speedy family to study whether copy number variation existed in these regions. Fst was calculated by VCFtools v0.1.14-30 [34] . Data process was performed with scripts, written in Java.
Gene expression analysis, survival analysis and co-expression network construction
The RNASeq data of 32 human normal tissues were downloaded from Human Protein Atlas Project [35] . Transcriptomic datasets of human prefrontal cortex were from [36] . Only one sample for each tissue was randomly selected to further analysis. Bam files of 734 cancer cell lines from 15 cancer types were downloaded from the CCLE project [37] . For normal tissue data, all reads were mapped to the human genome (GRCh37 in Gencode v25) by HISAT2 [38] . FPKM was calculated by Stringtie [39] for both human normal tissues and cancer cell lines data. We then calculated the tissue specificity of Speedy members using the method described in [40] . We also calculated the correlation of expression profile for each pair between Speedy members (expressed in more than one sample). We used a Pearson correlation coefficient >=0.8 and adjust p value <0.05 (Bonferroni correction) as criteria to determine whether a pair of Speedy members had similar expression profiles. Days-to-last-followup and days-to-death representing the number of days from initial pathological diagnosis to the last time the patient was known to be alive or dead , respectively, were extracted from TCGA clinical information and used to construct Kaplan-Meier survival curves by the R survMisc package [41] . To find a combination of gene signatures to predict survival with the expression of Speedy members, we first used the univariate Cox proportional-hazards model to eliminate genes, in which the absolute z score was less than 2. According to this criteria, all 7 members were retained. The multivariate Cox proportional-hazards regression model was used to select suitable combination of genes with backwards elimination algorithm by MASS package in R [42] . In the final model, we calculated risk score for each patient by sum up the product of log transformed FPKM and its corresponding coefficient from multivariate Cox proportional-hazards regression model. The formula was as follows: risk score = 0.553*SPDYA+0.195*SPDYE4+0.314*SPDYE6-0.516*SPDYE7P+0.364*SPDYE8P.
WGCNA [43] was used to construct weighted gene co-expression networks for normal tissues and cancer cell lines. We first manually removed those low expressed genes (FPKM<0.00001 in more than 90% samples). FPKM was then log-transformed by using log2(x+1). After sample clustering, outlier samples, (if they exist), were also removed from datasets. Retained genes and samples were used to calculate soft power (the smallest threshold making scale free topology with R >=0.9, which could result in a good balance between scale-free fitness, mean of connectivity and modularity).
This threshold was then used to calculate the topological overlap matrix (known as 1 0 TOM). The soft power for normal tissues was 3 and datasets of each kind of cancer type were listed in Table S6 .
ClueGO 2.3.2 [44] and CluePedia 1.3.2 [45] were used to functional enrichment analysis and visualization of genes which co-expressed with Speedy members. As co-expressed genes varied wildly among different Speedy members, we used different criteria to deal with this problem. When compared the functional enrichment of co-expressed genes in normal tissues, the parameter "min genes" were 7, 5 and 3 for SPDYE4, SPDYE1 and SPDYA, respectively. Parameter "%genes" were 8%, 6% and 4% for SPDYE4, SPDYE1 and SPDYA, respectively. When compared to the functional enrichment of co-expressed genes of SPDYE4 between normal tissues and HNSC, the same parameters were used. We used GO term fusion parameter to reduce the redundancy. Only Biological Process were used in our functional enrichment analysis.
MiRNA target prediction and ceRNA networks construction
We used 3 different microRNA target prediction tools to predict microRNA targets for 3'UTR of protein-coding genes and cdna of pseudogenes in Speedy family using human microRNA in miRBase release 21 as references. 
Results

The distribution and evolution of Speedy family genes
To comprehensively study the evolution of the Speedy family, we first identified all Speedy family protein-coding genes. According to our search strategy described in the methods, we found 544 Speedy genes in 258 eukaryotic species (Fig. 1a and Table S1 ).
These species belong to 11 phyla, 30 classes, 112 orders, 195 families, and 237 genera, respectively. All of the species belonged to Metazoa except for four species, which belonged to Ichthyosporea (Amoebidium parasiticum JAP-7-2 and Capsaspora owczarzaki ATCC 30864) and Amoebozoa (Dictyostelium fasciculatum and Dictyostelium purpureum), respectively. In Metazoa, the Mammalia, Aves, Clupeocephala, and Protostomia have more Speedy genes than other classes.
Interestingly, zebrafish contain Speedy genes, whereas carp fish do not. A Speedy gene is also found in the jewel wasp genome, but is absent in the bee and fruit fly genomes.
Overall, these data indicate that Speedy genes minimally originated before the common ancestor of Metazoa, and they are unevenly distributed across species.
We also found that the number of Speedy genes varied among species (Table S1 ).
More than half of the investigated species (148 of 258) contained only one Speedy gene. These species were mainly non-mammals (144 out of 148). In mammals, most species (76 out of 80) contained more than one Speedy gene. For instance, Catarrhini species contained at least four Speedy genes, and the human genome contains 10
Speedy protein-coding genes. Taken together, these data demonstrate that higher primate species possess more Speedy genes.
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To explore the evolutionary relationships among Speedy genes, we constructed a phylogenetic tree with the conserved region of the Spy1 domain of 15 representative species, using the maximum-likelihood method and A. parasiticum JAP-7-2 being as the outgroup. According to the phylogenetic tree, Speedy genes were divided into three subfamilies, designated as subfamilies A, C, and E following the name of the human Speedy gene in each clade (Fig. 1b) . Subfamily A exists in all selected species, suggesting that this subfamily originated first, while subfamilies C and E originated after A. Apparently, subfamily C was lost in mice, further supporting the uneven distribution of the Speedy family across species. Extensive expansion of Speedy subfamily E with a novel domain architecture was found in Homininae
In addition to the uneven distribution of Speedy genes across species, we also found that two distinct domains exist among Speedy proteins using InterProScan [15, 16] . species, and all of their low-identity domains are C-terminal, (named LSI-C). The others belong to Myotis davidii and Tupaia chinensis and are N-terminal. We identified one, seven, and 13 LSI-Cs genes in the gorilla, human, and chimpanzee genomes, respectively, and also found that most syntenic regions of human LSI-C genes were gaps in gorillas, indicating that the number of LSI-Cs in gorillas could be underestimated due to the quality of the gorilla genome (Table S2) . Clearly, LSI-Cs are new genes that recently originated in the common ancestor of Catarrhini and then extensively expanded in Homininae. According to the phylogenetic analysis, all LPI-Cs from Catarrhini were assigned to subfamily E (Fig. 1c) .
We further examined whether the low-Spy1-identity domain was functional or only displayed sequence similarity. After calculating the rate of nonsynonymous to synonymous nucleotide mutations (dN/dS) among low-Spy1-identity domain sequences across the Catarrhini, we found that > 90% of the dN/dS ratios were < 1 (Fig. S1a) , suggesting that they are subject to negative selection. This indicates that the low-Spy1-identity domain is functional.
We also investigated if the full-length Spy1 domains in subfamily E are undergoing positive selection. We used PAML and found that 15 amino acids (aa) in the Spy1 domain of subfamily E display positive selection. Among them, 12aa have posterior probabilities ≥ 0.95, and the others were ≥ 0.99 in the branch-site model test [30, 31] ( Fig. 1c) .
Furthermore, we also wondered whether the copies in subfamily E have divergent functions compared to those in subfamilies A and C. Second, in addition to testis, SPDYC genes were also expressed in the liver, small intestine, duodenum and placenta. Most E members were highly expressed in the testis except for SPDYE19P, SPDYE11, and SPDYE13P, which also had diverse 1 7 expression patterns in other normal tissues. Many of them were expressed in the spleen, bone marrow, skin, placenta, stomach, appendix, and lymph node. Although SPDYE19P, SPDYE11 and SPDYE13P are not expressed in the testis, they are expressed in other tissues with no obvious rules.
As new genes have been suggested to drive the development of the human brain, we examined the expression of Speedy genes in the human prefrontal cortex. The majority of Speedy genes were expressed in the prefrontal cortex (Fig. 3b) . In contrast, SPDYE2, SPDYE2B, and SPDYE6 from LSI-Cs had their highest expression levels in stages of fetal development and were decreased across other stages of life, indicating that they may play important roles in early brain development (Fig. 3b) (Fig. S2) . Within ceRNA networks, protein-coding genes and pseudogenes regulate each other. There were also many significant correlations between protein-coding genes and pseudogenes that do not show crosstalk via common miRNAs.
Combined with the origin of pseudogenes, we found that there were two modes of correlation between pseudogenes and their parental genes. First, the expression profile of pseudogenes correlates with their parental genes (e.g., SPDYE1 and SPDYE16 with their descendant pseudogenes). Furthermore, SPDYE20P and its parental gene SPDYE1 also share the miRNA target of has-miR-6730-3p ( Fig. 3d ), indicating that they could regulate each other via ceRNA. Second, the expression profile of pseudogenes does not correlate with their parental genes (e.g., SPDYE3 and SPDYE6
with their descendant pseudogenes). Moreover, pseudogenes (e.g. SPDYE8P, SPDYE10P, SPDYE15, and SPDYE17) from SPDYE3 display an expression correlation with other cognates, and SPDYE19P from SPDYE6 does not have any correlation with other members of the Speedy family ( Fig. 3c and S2 ).
Since genes in the same pathways or in the same functional complex often exhibit similar expression patterns under diverse temporal or physiological conditions, we examined their possible function(s) by determining co-expression gene networks. We 
Speedy family genes are associated with cancer
As Speedy genes are expressed in normal human tissues, we next examined whether they are also expressed in tumors. In 734 cancer cell lines (15 cancer types) from the Cancer Cell Line Encyclopedia (CCLE), most pseudogenes are expressed at a lower level in contrast to protein-coding genes ( Fig. 5a ). However, they do have similar expression profiles, which is consistent with results from normal tissues (Fig. 5b ). We only uncovered co-expression gene networks for Speedy members from bladder urothelial carcinoma (BLCA) and head and neck squamous cell carcinoma (HNSC).
SPDYE4 was the only Speedy member with a co-expression gene network in both normal tissues and HNSC, indicating its fundamental function (Fig. S3 ).
In addition to cancer cell lines, we further examined whether the Speedy members are expressed in human tumors by using The Cancer Genome Atlas (TCGA) data. Only 10 Speedy members were found in TCGA data. Eight out of 10 members have a higher expression level in acute myeloid leukemia (LAML) compared to other cancer types ( Fig. 5c ). Additionally, SPDYE2 and SPDYE7P also have a high expression level in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ)
2 0 compared to other cancer types. In paired data, we found that most members were significantly more highly expressed in tumors than corresponding normal tissues (Table S4 ). In contrast, SPDYC was significantly down regulated in three types of kidney cancer and liver hepatocellular carcinoma (LIHC). Five of six significantly differentially expressed genes were down regulated in thyroid carcinoma (THCA). In kidney renal clear cell carcinoma (KIRC), nine out of 10 members (except for SPDYE4) were all differentially expressed between tumors and their corresponding normal tissues.
We further examined whether these 10 Speedy members were associated with patient survival in 14 cancer types and found that their expression levels were predictive of patient survival. Especially in KIRC, a high expression level of seven Speedy members was all significantly associated with poor patient outcome. We also found that a combination of five Speedy members was significantly highly associated with overall survival in KIRC (Fig. 5d ). Although SPDYE4 did not display a significant expression difference between tumors and corresponding normal tissues in KIRC, prostate adenocarcinoma (PRAD) and skin cutaneous melanoma (SKCM), its expression level was able to predict patient survival (Table S5 ). In addition to protein-coding genes, SPDYE7P and SPDYE8P were also significantly associated with patient survival in KIRC/SKCM and HNSC/KIRC/Mesothelioma (MESO), respectively. Notably, SPDYA had an inverse relationship with patient survival among different cancer types (e.g., a higher expression level with longer survival in LAML and lung squamous cell carcinoma (LUSC) and a lower expression level with poor expression level of SPDYE6 was associated with the poor patient survival in KIRC, and UVM. However, low expression level of SPDYE6 was associated with the poor patient survival in DLBC (Fig. S4 ).
Overall, members of the Speedy family display different expression profiles and different associations with patient survival in different cancer types. This indicates that they may be related to cancer to some extent and are potential biomarkers for different cancer types.
Discussion
In this study, we comprehensively identified Speedy genes. Our analysis and the published eukaryotic species tree [51] revealed that Speedy is a very old gene.
Although there are two species in Amoebozoa containing Speedy genes, it can still be concluded that the Speedy gene originated at latest before the common ancestor of the Metazoa. This family was lost in many species, with no obvious taxonomic rules during evolution. The absence of the Speedy family could notbe completely attributed to incomplete genome sequences and/or annotations, e.g., fruit fly is well annotated, but we didn't find any Speedy genes in it. In addition to the existence bias across species, the number of Speedy genes varied among different species. However, it is 2 2 obvious that higher eukaryotes have more Speedy genes than lower ones. The uneven distribution of the Speedy family is also a functional hint that Speedy gene may be play roles in some subtle regulatory processes instead of being indispensable for life.
In this study, we used the comprehensive sequence dataset, so that the Speedy gene family could be further spilt into three subfamilies instead of two. As there were only two subfamily C genes (Speedy B4-like) in the previous study [14] , it would be possible that they were not distinguishable from the Speedy B subfamily [14] (corresponding to the Speedy E subfamily in this study). To clarify the situation, we followed the official gene names of the human Speedy genes approved by the HUGO Gene Nomenclature Committee and split the previous Speedy B subfamily genes [14] into the Speedy C and Speedy E subfamilies.
Gene duplication during evolution is one genetic source of gene family expansion, by means of acquiring genetic novelty in organisms [52] . When a paralog arises in an individual genome, it follows three evolutionary stages to maintain themselves in a population: fixation, fate-determination, and preservation [53] . In our study, a novel domain architecture was observed in Speedy subfamily E, and the poor-identity-spy1 domain is under negative selection, indicating that it has a potential unknown function.
Twenty-four human Speedy members were identified in our study. Among them, 10 are protein-coding genes, of which SPDYE5 and SPDYE16 also exist in both chimpanzees and gorillas with coding potential. This suggests that these two genes were already be functional in the common ancestor of the Homininae. Fourteen pseudogenes were also found in the human genome, which were all paralogs LSI-Cs show that they could bring both advantageous function and negative effects to organisms, which is consistent with the pleiotropy of new genes. Taken together with the positive selection on E members, it might be a consequence of further evolution to 'solve' a newly negative problems brought about by the fixation of new genes as compensatory changes, which is the derivation of selection, pleiotropy, and compensation hypothesis [64, 69] .
Conclusions
In general, our study shows that Speedy family genes are extensively expanded in the Homininae via the formation of a novel subfamily containing a low-Spy1-identity domain. Although they are still not completely fixed among Homininae and human populations after expansion, their expression profiles show that they have two distinct 
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